- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Cord Blood Stem Cells market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Cord Blood Stem Cells market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Autoimmune Diseases accounting for % of the Cord Blood Stem Cells global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Allogeneic Stem Cell segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Cord Blood Stem Cells include Advanced Cell Technology, California Stem Cell, Cytori Therapeutics, Mesoblast Limited, and Opexa Therapeutics Inc., etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Cord Blood Stem Cells market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Allogeneic Stem Cell
Autologous Stem Cell
Market segment by Application, can be divided into
Autoimmune Diseases
Immunodeficiencies
Malignancies,Caners
Solid Tumors
Others
Market segment by players, this report covers
Advanced Cell Technology
California Stem Cell
Cytori Therapeutics
Mesoblast Limited
Opexa Therapeutics Inc.
Athersys Inc.
Geron Corporation
Neostem Inc.
CBR Systems, Inc.
Cordlife
Cryo-Cell
Cryo-Save AG (A Group of Esperite)
Lifecell
Stemcyte
Viacord
Smart Cells International Ltd.
Cryoviva India
Cordvida
China Cord Blood Corporation
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Cord Blood Stem Cells product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Cord Blood Stem Cells, with revenue, gross margin and global market share of Cord Blood Stem Cells from 2019 to 2022.
Chapter 3, the Cord Blood Stem Cells competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Cord Blood Stem Cells market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Cord Blood Stem Cells research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Cord Blood Stem Cells
1.2 Classification of Cord Blood Stem Cells by Type
1.2.1 Overview: Global Cord Blood Stem Cells Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Cord Blood Stem Cells Revenue Market Share by Type in 2021
1.2.3 Allogeneic Stem Cell
1.2.4 Autologous Stem Cell
1.3 Global Cord Blood Stem Cells Market by Application
1.3.1 Overview: Global Cord Blood Stem Cells Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Autoimmune Diseases
1.3.3 Immunodeficiencies
1.3.4 Malignancies,Caners
1.3.5 Solid Tumors
1.3.6 Others
1.4 Global Cord Blood Stem Cells Market Size & Forecast
1.5 Global Cord Blood Stem Cells Market Size and Forecast by Region
1.5.1 Global Cord Blood Stem Cells Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Cord Blood Stem Cells Market Size by Region, (2017-2022)
1.5.3 North America Cord Blood Stem Cells Market Size and Prospect (2017-2028)
1.5.4 Europe Cord Blood Stem Cells Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Cord Blood Stem Cells Market Size and Prospect (2017-2028)
1.5.6 South America Cord Blood Stem Cells Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Cord Blood Stem Cells Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Cord Blood Stem Cells Market Drivers
1.6.2 Cord Blood Stem Cells Market Restraints
1.6.3 Cord Blood Stem Cells Trends Analysis
2 Company Profiles
2.1 Advanced Cell Technology
2.1.1 Advanced Cell Technology Details
2.1.2 Advanced Cell Technology Major Business
2.1.3 Advanced Cell Technology Cord Blood Stem Cells Product and Solutions
2.1.4 Advanced Cell Technology Cord Blood Stem Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Advanced Cell Technology Recent Developments and Future Plans
2.2 California Stem Cell
2.2.1 California Stem Cell Details
2.2.2 California Stem Cell Major Business
2.2.3 California Stem Cell Cord Blood Stem Cells Product and Solutions
2.2.4 California Stem Cell Cord Blood Stem Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 California Stem Cell Recent Developments and Future Plans
2.3 Cytori Therapeutics
2.3.1 Cytori Therapeutics Details
2.3.2 Cytori Therapeutics Major Business
2.3.3 Cytori Therapeutics Cord Blood Stem Cells Product and Solutions
2.3.4 Cytori Therapeutics Cord Blood Stem Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Cytori Therapeutics Recent Developments and Future Plans
2.4 Mesoblast Limited
2.4.1 Mesoblast Limited Details
2.4.2 Mesoblast Limited Major Business
2.4.3 Mesoblast Limited Cord Blood Stem Cells Product and Solutions
2.4.4 Mesoblast Limited Cord Blood Stem Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Mesoblast Limited Recent Developments and Future Plans
2.5 Opexa Therapeutics Inc.
2.5.1 Opexa Therapeutics Inc. Details
2.5.2 Opexa Therapeutics Inc. Major Business
2.5.3 Opexa Therapeutics Inc. Cord Blood Stem Cells Product and Solutions
2.5.4 Opexa Therapeutics Inc. Cord Blood Stem Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Opexa Therapeutics Inc. Recent Developments and Future Plans
2.6 Athersys Inc.
2.6.1 Athersys Inc. Details
2.6.2 Athersys Inc. Major Business
2.6.3 Athersys Inc. Cord Blood Stem Cells Product and Solutions
2.6.4 Athersys Inc. Cord Blood Stem Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Athersys Inc. Recent Developments and Future Plans
2.7 Geron Corporation
2.7.1 Geron Corporation Details
2.7.2 Geron Corporation Major Business
2.7.3 Geron Corporation Cord Blood Stem Cells Product and Solutions
2.7.4 Geron Corporation Cord Blood Stem Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Geron Corporation Recent Developments and Future Plans
2.8 Neostem Inc.
2.8.1 Neostem Inc. Details
2.8.2 Neostem Inc. Major Business
2.8.3 Neostem Inc. Cord Blood Stem Cells Product and Solutions
2.8.4 Neostem Inc. Cord Blood Stem Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Neostem Inc. Recent Developments and Future Plans
2.9 CBR Systems, Inc.
2.9.1 CBR Systems, Inc. Details
2.9.2 CBR Systems, Inc. Major Business
2.9.3 CBR Systems, Inc. Cord Blood Stem Cells Product and Solutions
2.9.4 CBR Systems, Inc. Cord Blood Stem Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 CBR Systems, Inc. Recent Developments and Future Plans
2.10 Cordlife
2.10.1 Cordlife Details
2.10.2 Cordlife Major Business
2.10.3 Cordlife Cord Blood Stem Cells Product and Solutions
2.10.4 Cordlife Cord Blood Stem Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Cordlife Recent Developments and Future Plans
2.11 Cryo-Cell
2.11.1 Cryo-Cell Details
2.11.2 Cryo-Cell Major Business
2.11.3 Cryo-Cell Cord Blood Stem Cells Product and Solutions
2.11.4 Cryo-Cell Cord Blood Stem Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Cryo-Cell Recent Developments and Future Plans
2.12 Cryo-Save AG (A Group of Esperite)
2.12.1 Cryo-Save AG (A Group of Esperite) Details
2.12.2 Cryo-Save AG (A Group of Esperite) Major Business
2.12.3 Cryo-Save AG (A Group of Esperite) Cord Blood Stem Cells Product and Solutions
2.12.4 Cryo-Save AG (A Group of Esperite) Cord Blood Stem Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Cryo-Save AG (A Group of Esperite) Recent Developments and Future Plans
2.13 Lifecell
2.13.1 Lifecell Details
2.13.2 Lifecell Major Business
2.13.3 Lifecell Cord Blood Stem Cells Product and Solutions
2.13.4 Lifecell Cord Blood Stem Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Lifecell Recent Developments and Future Plans
2.14 Stemcyte
2.14.1 Stemcyte Details
2.14.2 Stemcyte Major Business
2.14.3 Stemcyte Cord Blood Stem Cells Product and Solutions
2.14.4 Stemcyte Cord Blood Stem Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Stemcyte Recent Developments and Future Plans
2.15 Viacord
2.15.1 Viacord Details
2.15.2 Viacord Major Business
2.15.3 Viacord Cord Blood Stem Cells Product and Solutions
2.15.4 Viacord Cord Blood Stem Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Viacord Recent Developments and Future Plans
2.16 Smart Cells International Ltd.
2.16.1 Smart Cells International Ltd. Details
2.16.2 Smart Cells International Ltd. Major Business
2.16.3 Smart Cells International Ltd. Cord Blood Stem Cells Product and Solutions
2.16.4 Smart Cells International Ltd. Cord Blood Stem Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 Smart Cells International Ltd. Recent Developments and Future Plans
2.17 Cryoviva India
2.17.1 Cryoviva India Details
2.17.2 Cryoviva India Major Business
2.17.3 Cryoviva India Cord Blood Stem Cells Product and Solutions
2.17.4 Cryoviva India Cord Blood Stem Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17.5 Cryoviva India Recent Developments and Future Plans
2.18 Cordvida
2.18.1 Cordvida Details
2.18.2 Cordvida Major Business
2.18.3 Cordvida Cord Blood Stem Cells Product and Solutions
2.18.4 Cordvida Cord Blood Stem Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18.5 Cordvida Recent Developments and Future Plans
2.19 China Cord Blood Corporation
2.19.1 China Cord Blood Corporation Details
2.19.2 China Cord Blood Corporation Major Business
2.19.3 China Cord Blood Corporation Cord Blood Stem Cells Product and Solutions
2.19.4 China Cord Blood Corporation Cord Blood Stem Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19.5 China Cord Blood Corporation Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Cord Blood Stem Cells Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Cord Blood Stem Cells Players Market Share in 2021
3.2.2 Top 10 Cord Blood Stem Cells Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Cord Blood Stem Cells Players Head Office, Products and Services Provided
3.4 Cord Blood Stem Cells Mergers & Acquisitions
3.5 Cord Blood Stem Cells New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Cord Blood Stem Cells Revenue and Market Share by Type (2017-2022)
4.2 Global Cord Blood Stem Cells Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Cord Blood Stem Cells Revenue Market Share by Application (2017-2022)
5.2 Global Cord Blood Stem Cells Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Cord Blood Stem Cells Revenue by Type (2017-2028)
6.2 North America Cord Blood Stem Cells Revenue by Application (2017-2028)
6.3 North America Cord Blood Stem Cells Market Size by Country
6.3.1 North America Cord Blood Stem Cells Revenue by Country (2017-2028)
6.3.2 United States Cord Blood Stem Cells Market Size and Forecast (2017-2028)
6.3.3 Canada Cord Blood Stem Cells Market Size and Forecast (2017-2028)
6.3.4 Mexico Cord Blood Stem Cells Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Cord Blood Stem Cells Revenue by Type (2017-2028)
7.2 Europe Cord Blood Stem Cells Revenue by Application (2017-2028)
7.3 Europe Cord Blood Stem Cells Market Size by Country
7.3.1 Europe Cord Blood Stem Cells Revenue by Country (2017-2028)
7.3.2 Germany Cord Blood Stem Cells Market Size and Forecast (2017-2028)
7.3.3 France Cord Blood Stem Cells Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Cord Blood Stem Cells Market Size and Forecast (2017-2028)
7.3.5 Russia Cord Blood Stem Cells Market Size and Forecast (2017-2028)
7.3.6 Italy Cord Blood Stem Cells Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Cord Blood Stem Cells Revenue by Type (2017-2028)
8.2 Asia-Pacific Cord Blood Stem Cells Revenue by Application (2017-2028)
8.3 Asia-Pacific Cord Blood Stem Cells Market Size by Region
8.3.1 Asia-Pacific Cord Blood Stem Cells Revenue by Region (2017-2028)
8.3.2 China Cord Blood Stem Cells Market Size and Forecast (2017-2028)
8.3.3 Japan Cord Blood Stem Cells Market Size and Forecast (2017-2028)
8.3.4 South Korea Cord Blood Stem Cells Market Size and Forecast (2017-2028)
8.3.5 India Cord Blood Stem Cells Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Cord Blood Stem Cells Market Size and Forecast (2017-2028)
8.3.7 Australia Cord Blood Stem Cells Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Cord Blood Stem Cells Revenue by Type (2017-2028)
9.2 South America Cord Blood Stem Cells Revenue by Application (2017-2028)
9.3 South America Cord Blood Stem Cells Market Size by Country
9.3.1 South America Cord Blood Stem Cells Revenue by Country (2017-2028)
9.3.2 Brazil Cord Blood Stem Cells Market Size and Forecast (2017-2028)
9.3.3 Argentina Cord Blood Stem Cells Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Cord Blood Stem Cells Revenue by Type (2017-2028)
10.2 Middle East & Africa Cord Blood Stem Cells Revenue by Application (2017-2028)
10.3 Middle East & Africa Cord Blood Stem Cells Market Size by Country
10.3.1 Middle East & Africa Cord Blood Stem Cells Revenue by Country (2017-2028)
10.3.2 Turkey Cord Blood Stem Cells Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Cord Blood Stem Cells Market Size and Forecast (2017-2028)
10.3.4 UAE Cord Blood Stem Cells Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Cord Blood Stem Cells Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Cord Blood Stem Cells Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Cord Blood Stem Cells Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Cord Blood Stem Cells Revenue (USD Million) by Region (2017-2022)
Table 5. Global Cord Blood Stem Cells Revenue Market Share by Region (2023-2028)
Table 6. Advanced Cell Technology Corporate Information, Head Office, and Major Competitors
Table 7. Advanced Cell Technology Major Business
Table 8. Advanced Cell Technology Cord Blood Stem Cells Product and Solutions
Table 9. Advanced Cell Technology Cord Blood Stem Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. California Stem Cell Corporate Information, Head Office, and Major Competitors
Table 11. California Stem Cell Major Business
Table 12. California Stem Cell Cord Blood Stem Cells Product and Solutions
Table 13. California Stem Cell Cord Blood Stem Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Cytori Therapeutics Corporate Information, Head Office, and Major Competitors
Table 15. Cytori Therapeutics Major Business
Table 16. Cytori Therapeutics Cord Blood Stem Cells Product and Solutions
Table 17. Cytori Therapeutics Cord Blood Stem Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Mesoblast Limited Corporate Information, Head Office, and Major Competitors
Table 19. Mesoblast Limited Major Business
Table 20. Mesoblast Limited Cord Blood Stem Cells Product and Solutions
Table 21. Mesoblast Limited Cord Blood Stem Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Opexa Therapeutics Inc. Corporate Information, Head Office, and Major Competitors
Table 23. Opexa Therapeutics Inc. Major Business
Table 24. Opexa Therapeutics Inc. Cord Blood Stem Cells Product and Solutions
Table 25. Opexa Therapeutics Inc. Cord Blood Stem Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Athersys Inc. Corporate Information, Head Office, and Major Competitors
Table 27. Athersys Inc. Major Business
Table 28. Athersys Inc. Cord Blood Stem Cells Product and Solutions
Table 29. Athersys Inc. Cord Blood Stem Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Geron Corporation Corporate Information, Head Office, and Major Competitors
Table 31. Geron Corporation Major Business
Table 32. Geron Corporation Cord Blood Stem Cells Product and Solutions
Table 33. Geron Corporation Cord Blood Stem Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Neostem Inc. Corporate Information, Head Office, and Major Competitors
Table 35. Neostem Inc. Major Business
Table 36. Neostem Inc. Cord Blood Stem Cells Product and Solutions
Table 37. Neostem Inc. Cord Blood Stem Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. CBR Systems, Inc. Corporate Information, Head Office, and Major Competitors
Table 39. CBR Systems, Inc. Major Business
Table 40. CBR Systems, Inc. Cord Blood Stem Cells Product and Solutions
Table 41. CBR Systems, Inc. Cord Blood Stem Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Cordlife Corporate Information, Head Office, and Major Competitors
Table 43. Cordlife Major Business
Table 44. Cordlife Cord Blood Stem Cells Product and Solutions
Table 45. Cordlife Cord Blood Stem Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Cryo-Cell Corporate Information, Head Office, and Major Competitors
Table 47. Cryo-Cell Major Business
Table 48. Cryo-Cell Cord Blood Stem Cells Product and Solutions
Table 49. Cryo-Cell Cord Blood Stem Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Cryo-Save AG (A Group of Esperite) Corporate Information, Head Office, and Major Competitors
Table 51. Cryo-Save AG (A Group of Esperite) Major Business
Table 52. Cryo-Save AG (A Group of Esperite) Cord Blood Stem Cells Product and Solutions
Table 53. Cryo-Save AG (A Group of Esperite) Cord Blood Stem Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Lifecell Corporate Information, Head Office, and Major Competitors
Table 55. Lifecell Major Business
Table 56. Lifecell Cord Blood Stem Cells Product and Solutions
Table 57. Lifecell Cord Blood Stem Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Stemcyte Corporate Information, Head Office, and Major Competitors
Table 59. Stemcyte Major Business
Table 60. Stemcyte Cord Blood Stem Cells Product and Solutions
Table 61. Stemcyte Cord Blood Stem Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Viacord Corporate Information, Head Office, and Major Competitors
Table 63. Viacord Major Business
Table 64. Viacord Cord Blood Stem Cells Product and Solutions
Table 65. Viacord Cord Blood Stem Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Smart Cells International Ltd. Corporate Information, Head Office, and Major Competitors
Table 67. Smart Cells International Ltd. Major Business
Table 68. Smart Cells International Ltd. Cord Blood Stem Cells Product and Solutions
Table 69. Smart Cells International Ltd. Cord Blood Stem Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Cryoviva India Corporate Information, Head Office, and Major Competitors
Table 71. Cryoviva India Major Business
Table 72. Cryoviva India Cord Blood Stem Cells Product and Solutions
Table 73. Cryoviva India Cord Blood Stem Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 74. Cordvida Corporate Information, Head Office, and Major Competitors
Table 75. Cordvida Major Business
Table 76. Cordvida Cord Blood Stem Cells Product and Solutions
Table 77. Cordvida Cord Blood Stem Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 78. China Cord Blood Corporation Corporate Information, Head Office, and Major Competitors
Table 79. China Cord Blood Corporation Major Business
Table 80. China Cord Blood Corporation Cord Blood Stem Cells Product and Solutions
Table 81. China Cord Blood Corporation Cord Blood Stem Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 82. Global Cord Blood Stem Cells Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 83. Global Cord Blood Stem Cells Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 84. Breakdown of Cord Blood Stem Cells by Company Type (Tier 1, Tier 2 and Tier 3)
Table 85. Cord Blood Stem Cells Players Head Office, Products and Services Provided
Table 86. Cord Blood Stem Cells Mergers & Acquisitions in the Past Five Years
Table 87. Cord Blood Stem Cells New Entrants and Expansion Plans
Table 88. Global Cord Blood Stem Cells Revenue (USD Million) by Type (2017-2022)
Table 89. Global Cord Blood Stem Cells Revenue Share by Type (2017-2022)
Table 90. Global Cord Blood Stem Cells Revenue Forecast by Type (2023-2028)
Table 91. Global Cord Blood Stem Cells Revenue by Application (2017-2022)
Table 92. Global Cord Blood Stem Cells Revenue Forecast by Application (2023-2028)
Table 93. North America Cord Blood Stem Cells Revenue by Type (2017-2022) & (USD Million)
Table 94. North America Cord Blood Stem Cells Revenue by Type (2023-2028) & (USD Million)
Table 95. North America Cord Blood Stem Cells Revenue by Application (2017-2022) & (USD Million)
Table 96. North America Cord Blood Stem Cells Revenue by Application (2023-2028) & (USD Million)
Table 97. North America Cord Blood Stem Cells Revenue by Country (2017-2022) & (USD Million)
Table 98. North America Cord Blood Stem Cells Revenue by Country (2023-2028) & (USD Million)
Table 99. Europe Cord Blood Stem Cells Revenue by Type (2017-2022) & (USD Million)
Table 100. Europe Cord Blood Stem Cells Revenue by Type (2023-2028) & (USD Million)
Table 101. Europe Cord Blood Stem Cells Revenue by Application (2017-2022) & (USD Million)
Table 102. Europe Cord Blood Stem Cells Revenue by Application (2023-2028) & (USD Million)
Table 103. Europe Cord Blood Stem Cells Revenue by Country (2017-2022) & (USD Million)
Table 104. Europe Cord Blood Stem Cells Revenue by Country (2023-2028) & (USD Million)
Table 105. Asia-Pacific Cord Blood Stem Cells Revenue by Type (2017-2022) & (USD Million)
Table 106. Asia-Pacific Cord Blood Stem Cells Revenue by Type (2023-2028) & (USD Million)
Table 107. Asia-Pacific Cord Blood Stem Cells Revenue by Application (2017-2022) & (USD Million)
Table 108. Asia-Pacific Cord Blood Stem Cells Revenue by Application (2023-2028) & (USD Million)
Table 109. Asia-Pacific Cord Blood Stem Cells Revenue by Region (2017-2022) & (USD Million)
Table 110. Asia-Pacific Cord Blood Stem Cells Revenue by Region (2023-2028) & (USD Million)
Table 111. South America Cord Blood Stem Cells Revenue by Type (2017-2022) & (USD Million)
Table 112. South America Cord Blood Stem Cells Revenue by Type (2023-2028) & (USD Million)
Table 113. South America Cord Blood Stem Cells Revenue by Application (2017-2022) & (USD Million)
Table 114. South America Cord Blood Stem Cells Revenue by Application (2023-2028) & (USD Million)
Table 115. South America Cord Blood Stem Cells Revenue by Country (2017-2022) & (USD Million)
Table 116. South America Cord Blood Stem Cells Revenue by Country (2023-2028) & (USD Million)
Table 117. Middle East & Africa Cord Blood Stem Cells Revenue by Type (2017-2022) & (USD Million)
Table 118. Middle East & Africa Cord Blood Stem Cells Revenue by Type (2023-2028) & (USD Million)
Table 119. Middle East & Africa Cord Blood Stem Cells Revenue by Application (2017-2022) & (USD Million)
Table 120. Middle East & Africa Cord Blood Stem Cells Revenue by Application (2023-2028) & (USD Million)
Table 121. Middle East & Africa Cord Blood Stem Cells Revenue by Country (2017-2022) & (USD Million)
Table 122. Middle East & Africa Cord Blood Stem Cells Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Cord Blood Stem Cells Picture
Figure 2. Global Cord Blood Stem Cells Revenue Market Share by Type in 2021
Figure 3. Allogeneic Stem Cell
Figure 4. Autologous Stem Cell
Figure 5. Cord Blood Stem Cells Revenue Market Share by Application in 2021
Figure 6. Autoimmune Diseases Picture
Figure 7. Immunodeficiencies Picture
Figure 8. Malignancies,Caners Picture
Figure 9. Solid Tumors Picture
Figure 10. Others Picture
Figure 11. Global Cord Blood Stem Cells Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 12. Global Cord Blood Stem Cells Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Cord Blood Stem Cells Revenue Market Share by Region (2017-2028)
Figure 14. Global Cord Blood Stem Cells Revenue Market Share by Region in 2021
Figure 15. North America Cord Blood Stem Cells Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Europe Cord Blood Stem Cells Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Asia-Pacific Cord Blood Stem Cells Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. South America Cord Blood Stem Cells Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Middle East and Africa Cord Blood Stem Cells Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Cord Blood Stem Cells Market Drivers
Figure 21. Cord Blood Stem Cells Market Restraints
Figure 22. Cord Blood Stem Cells Market Trends
Figure 23. Advanced Cell Technology Recent Developments and Future Plans
Figure 24. California Stem Cell Recent Developments and Future Plans
Figure 25. Cytori Therapeutics Recent Developments and Future Plans
Figure 26. Mesoblast Limited Recent Developments and Future Plans
Figure 27. Opexa Therapeutics Inc. Recent Developments and Future Plans
Figure 28. Athersys Inc. Recent Developments and Future Plans
Figure 29. Geron Corporation Recent Developments and Future Plans
Figure 30. Neostem Inc. Recent Developments and Future Plans
Figure 31. CBR Systems, Inc. Recent Developments and Future Plans
Figure 32. Cordlife Recent Developments and Future Plans
Figure 33. Cryo-Cell Recent Developments and Future Plans
Figure 34. Cryo-Save AG (A Group of Esperite) Recent Developments and Future Plans
Figure 35. Lifecell Recent Developments and Future Plans
Figure 36. Stemcyte Recent Developments and Future Plans
Figure 37. Viacord Recent Developments and Future Plans
Figure 38. Smart Cells International Ltd. Recent Developments and Future Plans
Figure 39. Cryoviva India Recent Developments and Future Plans
Figure 40. Cordvida Recent Developments and Future Plans
Figure 41. China Cord Blood Corporation Recent Developments and Future Plans
Figure 42. Global Cord Blood Stem Cells Revenue Share by Players in 2021
Figure 43. Cord Blood Stem Cells Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 44. Global Top 3 Players Cord Blood Stem Cells Revenue Market Share in 2021
Figure 45. Global Top 10 Players Cord Blood Stem Cells Revenue Market Share in 2021
Figure 46. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 47. Global Cord Blood Stem Cells Revenue Share by Type in 2021
Figure 48. Global Cord Blood Stem Cells Market Share Forecast by Type (2023-2028)
Figure 49. Global Cord Blood Stem Cells Revenue Share by Application in 2021
Figure 50. Global Cord Blood Stem Cells Market Share Forecast by Application (2023-2028)
Figure 51. North America Cord Blood Stem Cells Sales Market Share by Type (2017-2028)
Figure 52. North America Cord Blood Stem Cells Sales Market Share by Application (2017-2028)
Figure 53. North America Cord Blood Stem Cells Revenue Market Share by Country (2017-2028)
Figure 54. United States Cord Blood Stem Cells Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Canada Cord Blood Stem Cells Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Mexico Cord Blood Stem Cells Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Europe Cord Blood Stem Cells Sales Market Share by Type (2017-2028)
Figure 58. Europe Cord Blood Stem Cells Sales Market Share by Application (2017-2028)
Figure 59. Europe Cord Blood Stem Cells Revenue Market Share by Country (2017-2028)
Figure 60. Germany Cord Blood Stem Cells Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. France Cord Blood Stem Cells Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. United Kingdom Cord Blood Stem Cells Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Russia Cord Blood Stem Cells Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Italy Cord Blood Stem Cells Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Asia-Pacific Cord Blood Stem Cells Sales Market Share by Type (2017-2028)
Figure 66. Asia-Pacific Cord Blood Stem Cells Sales Market Share by Application (2017-2028)
Figure 67. Asia-Pacific Cord Blood Stem Cells Revenue Market Share by Region (2017-2028)
Figure 68. China Cord Blood Stem Cells Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Japan Cord Blood Stem Cells Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. South Korea Cord Blood Stem Cells Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. India Cord Blood Stem Cells Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Southeast Asia Cord Blood Stem Cells Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Australia Cord Blood Stem Cells Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South America Cord Blood Stem Cells Sales Market Share by Type (2017-2028)
Figure 75. South America Cord Blood Stem Cells Sales Market Share by Application (2017-2028)
Figure 76. South America Cord Blood Stem Cells Revenue Market Share by Country (2017-2028)
Figure 77. Brazil Cord Blood Stem Cells Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Argentina Cord Blood Stem Cells Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Middle East and Africa Cord Blood Stem Cells Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Cord Blood Stem Cells Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Cord Blood Stem Cells Revenue Market Share by Country (2017-2028)
Figure 82. Turkey Cord Blood Stem Cells Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. Saudi Arabia Cord Blood Stem Cells Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 84. UAE Cord Blood Stem Cells Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 85. Methodology
Figure 86. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
